Ordering Recommendation

Use to evaluate rapid-onset neurologic symptoms associated with spinal cord dysfunction.

Testing in both serum and CSF is recommended to maximize diagnostic yield; refer to Autoimmune Myelopathy Panel, CSF (3006209) for CSF testing.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation

N/A

Collect

Serum separator tube (SST)

Specimen Preparation

Separate from cells ASAP or within 2 hours of collection. Transfer three 1 mL serum aliquots to ARUP standard transport tubes. (Min: 0.5 mL/aliquot)

Storage/Transport Temperature

Frozen

Unacceptable Conditions

Amniotic fluid, ocular fluid, peritoneal fluid, synovial fluid, CSF, or plasma. Contaminated, hemolyzed, icteric, or lipemic specimens.

Remarks
Stability

After separation from cells: Ambient: 24 hours; Refrigerated: 1 week; Frozen: 1 month (avoid repeated freeze/thaw cycles)

Methodology

Semi-Quantitative Cell-Based Indirect Fluorescent Antibody/Semi-Quantitative Indirect Fluorescent Antibody (IFA)/Qualitative Immunoblot/Semi-Quantitative Enzyme-Linked Immunosorbent Assay (ELISA)

Performed

Varies

Reported

3-10 days

Reference Interval

Test Number
Components
Reference Interval
  CV2 Ab IgG CBA-IFA Screen, Serum Less than 1:100
  Neuronal Antibody (Amphiphysin) Negative
  Glutamic Acid Decarboxylase Antibody 0.0-5.0 IU/mL
  Purkinje Cell/Neuronal Nuclear IgG Scrn None Detected
  SOX1 Antibody, IgG by Immunoblot, Serum Negative
  NMO/AQP4 Ab IgG CBA-IFA Screen, Serum Less than 1:10
  GABA-BR Ab IgG CBA-IFA Scrn, Ser Less than 1:10
  MOG Ab IgG CBA-IFA Screen, Serum Less than 1:10
  DPPX Ab IgG CBA-IFA Screen, Serum Less than 1:10
  mGluR1 Ab IgG CBA-IFA Screen, Serum Less than 1:10

Interpretive Data

Refer to report

Compliance Category

Laboratory Developed Test (LDT)

Note

If CV2 antibody IgG is positive, then titer will be added. Additional charges apply.
PCCA/ANNA antibody IgG is screened by IFA. If the IFA screen is indeterminate, then a Neuronal Nuclear Antibodies (Hu, Ri, Yo, and Tr/DNER) IgG by Immunoblot will be performed. If the IFA screen is positive at 1:10 or greater, then a PCCA/ANNA antibodies titer and Neuronal Nuclear Antibodies (Hu, Ri, Yo, Tr/DNER) IgG by Immunoblot will be performed. Additional charges apply.
If DPPX antibody IgG by IFA is positive, then titer will be added. Additional charges apply.
If AQP4/NMO antibody IgG by IFA is positive, then titer will be added. Additional charges apply.
If mGluR1 antibody IgG by IFA is positive, then titer will be added. Additional charges apply.
If MOG antibody IgG by IFA is positive, then titer will be added. Additional charges apply.
If GABA-BR antibody IgG by IFA is positive, then titer will be added. Additional charges apply.

Hotline History

N/A

CPT Codes

86341; 86362; 86052; 84182 x2; 86255 x5; if reflexed add 84182 x4; 86256 per titer

Components

Component Test Code* Component Chart Name LOINC
0051709 Neuronal Antibody (Amphiphysin) 94385-2
2001772 Glutamic Acid Decarboxylase Antibody 56540-8
2007962 Purkinje Cell/Neuronal Nuclear IgG Scrn 61177-2
2013322 NMO/AQP4 Ab IgG CBA-IFA Screen, Serum 63439-4
2013959 CV2 Ab IgG CBA-IFA Screen, Serum 72504-4
3001271 GABA-BR Ab IgG CBA-IFA Scrn, Ser 93428-1
3001278 MOG Ab IgG CBA-IFA Screen, Serum 91545-4
3002903 SOX1 Antibody, IgG by Immunoblot, Serum 82444-1
3004361 DPPX Ab IgG CBA-IFA Screen, Serum 94676-4
3006045 mGluR1 Ab IgG CBA-IFA Screen, Serum 93498-4
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • NMO
  • AGNA
  • Amphiphysin
  • ANNA
  • Anti-glial nuclear antibody
  • Anti-neuronal nuclear antibody
  • AQP4
  • Aquaporin 4
  • Contactin-associated protein-like-2
  • CRMP-5
  • CV2
  • Dipeptidyl aminopeptidase-like protein 6
  • DPPX
  • GAD65
  • Glutamic acid decarboxylase
  • Hu
  • metabotropic glutamate receptor 1
  • mGluR1
  • MOG
  • Myelin oligodendrocyte glycoprotein
  • Myelopathy, Neuromyelitis optica
  • NMOSD
  • Paraneoplastic myelopathy
  • PCA
  • PCCA
  • Purkinje cell cytoplasmic antibody
  • Ri
  • Yo
Autoimmune Myelopathy Panel, Serum